192 related articles for article (PubMed ID: 32265300)
1. Knock-in rats with homozygous
Tambini MD; D'Adamio L
J Biol Chem; 2020 May; 295(21):7442-7451. PubMed ID: 32265300
[TBL] [Abstract][Full Text] [Related]
2. Aβ43 levels determine the onset of pathological amyloid deposition.
Tambini MD; Yin T; Yesiltepe M; Breuillaud L; Zehntner SP; d'Abramo C; Giliberto L; D'Adamio L
J Biol Chem; 2023 Jul; 299(7):104868. PubMed ID: 37257821
[TBL] [Abstract][Full Text] [Related]
3. Loss of Aβ43 Production Caused by Presenilin-1 Mutations in the Knockin Mouse Brain.
Xia D; Kelleher RJ; Shen J
Neuron; 2016 Apr; 90(2):417-22. PubMed ID: 27100200
[TBL] [Abstract][Full Text] [Related]
4. Novel presenilin 1 and 2 double knock-out cell line for in vitro validation of PSEN1 and PSEN2 mutations.
Pimenova AA; Goate AM
Neurobiol Dis; 2020 May; 138():104785. PubMed ID: 32032730
[TBL] [Abstract][Full Text] [Related]
5. Familial Alzheimer's disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.
Arber C; Toombs J; Lovejoy C; Ryan NS; Paterson RW; Willumsen N; Gkanatsiou E; Portelius E; Blennow K; Heslegrave A; Schott JM; Hardy J; Lashley T; Fox NC; Zetterberg H; Wray S
Mol Psychiatry; 2020 Nov; 25(11):2919-2931. PubMed ID: 30980041
[TBL] [Abstract][Full Text] [Related]
6. Human Presenilin-1 delivered by AAV9 rescues impaired γ-secretase activity, memory deficits, and neurodegeneration in
Montenegro P; Chen P; Kang J; Lee SH; Leone S; Shen J
Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2306714120. PubMed ID: 37816062
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Non-Amyloidogenic Mutations in APP Supports Loss of Function Hypothesis of Alzheimer's Disease.
Kim M; Bezprozvanny I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768421
[TBL] [Abstract][Full Text] [Related]
8. Familial Alzheimer's Disease Mutations in Presenilin Generate Amyloidogenic Aβ Peptide Seeds.
Veugelen S; Saito T; Saido TC; Chávez-Gutiérrez L; De Strooper B
Neuron; 2016 Apr; 90(2):410-6. PubMed ID: 27100199
[TBL] [Abstract][Full Text] [Related]
9. Pathogenic Aβ production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1.
Kurth V; Ogorek I; Münch C; Lopez-Rios J; Ousson S; Lehmann S; Nieweg K; Roebroek AJM; Pietrzik CU; Beher D; Weggen S
J Biol Chem; 2023 Aug; 299(8):104997. PubMed ID: 37394008
[TBL] [Abstract][Full Text] [Related]
10. The Alzheimer Disease-Causing Presenilin-1 L435F Mutation Causes Increased Production of Soluble Aβ43 Species in Patient-Derived iPSC-Neurons, Closely Mimicking Matched Patient Brain Tissue.
Oakley DH; Chung M; Klickstein N; Commins C; Hyman BT; Frosch MP
J Neuropathol Exp Neurol; 2020 Jun; 79(6):592-604. PubMed ID: 32388561
[TBL] [Abstract][Full Text] [Related]
11. Alzheimer presenilin-1 mutations dramatically reduce trimming of long amyloid β-peptides (Aβ) by γ-secretase to increase 42-to-40-residue Aβ.
Fernandez MA; Klutkowski JA; Freret T; Wolfe MS
J Biol Chem; 2014 Nov; 289(45):31043-52. PubMed ID: 25239621
[TBL] [Abstract][Full Text] [Related]
12. Generation and deposition of Aβ43 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer's disease.
Kretner B; Trambauer J; Fukumori A; Mielke J; Kuhn PH; Kremmer E; Giese A; Lichtenthaler SF; Haass C; Arzberger T; Steiner H
EMBO Mol Med; 2016 May; 8(5):458-65. PubMed ID: 26988102
[TBL] [Abstract][Full Text] [Related]
13. Presenilin-1 knockin mice reveal loss-of-function mechanism for familial Alzheimer's disease.
Xia D; Watanabe H; Wu B; Lee SH; Li Y; Tsvetkov E; Bolshakov VY; Shen J; Kelleher RJ
Neuron; 2015 Mar; 85(5):967-81. PubMed ID: 25741723
[TBL] [Abstract][Full Text] [Related]
14. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
[TBL] [Abstract][Full Text] [Related]
15. Dominant negative effect of the loss-of-function γ-secretase mutants on the wild-type enzyme through heterooligomerization.
Zhou R; Yang G; Shi Y
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12731-12736. PubMed ID: 29078389
[TBL] [Abstract][Full Text] [Related]
16. Switched Aβ43 generation in familial Alzheimer's disease with presenilin 1 mutation.
Kakuda N; Takami M; Okochi M; Kasuga K; Ihara Y; Ikeuchi T
Transl Psychiatry; 2021 Nov; 11(1):558. PubMed ID: 34728605
[TBL] [Abstract][Full Text] [Related]
17. Characterization of FRM-36143 as a new γ-secretase modulator for the potential treatment of familial Alzheimer's disease.
Blain JF; Bursavich MG; Freeman EA; Hrdlicka LA; Hodgdon HE; Chen T; Costa DE; Harrison BA; Kapadnis S; Murphy DA; Nolan S; Tu Z; Tang C; Burnett DA; Patzke H; Koenig G
Alzheimers Res Ther; 2016 Aug; 8(1):34. PubMed ID: 27572246
[TBL] [Abstract][Full Text] [Related]
18. Familial Alzheimer's disease mutations in amyloid protein precursor alter proteolysis by γ-secretase to increase amyloid β-peptides of ≥45 residues.
Devkota S; Williams TD; Wolfe MS
J Biol Chem; 2021; 296():100281. PubMed ID: 33450230
[TBL] [Abstract][Full Text] [Related]
19. Enzymatic characteristics of I213T mutant presenilin-1/gamma-secretase in cell models and knock-in mouse brains: familial Alzheimer disease-linked mutation impairs gamma-site cleavage of amyloid precursor protein C-terminal fragment beta.
Shimojo M; Sahara N; Mizoroki T; Funamoto S; Morishima-Kawashima M; Kudo T; Takeda M; Ihara Y; Ichinose H; Takashima A
J Biol Chem; 2008 Jun; 283(24):16488-96. PubMed ID: 18430735
[TBL] [Abstract][Full Text] [Related]
20. Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
Serneels L; T'Syen D; Perez-Benito L; Theys T; Holt MG; De Strooper B
Mol Neurodegener; 2020 Oct; 15(1):60. PubMed ID: 33076948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
